Biological
Measles Vaccine clinical trials
Keep track of what changes. Save the Measles Vaccine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
17 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 15
Bandim Health Project (8) · PATH (2) · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (2) · GlaxoSmithKline (1) · Sanofi Pasteur, a Sanofi Company (1) · International Vaccine Institute (1) · University of Witwatersrand, South Africa (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1)
Often tested with
Tested in the same studies.
Rubella Vaccine (5) · Yellow Fever Vaccine (2) · R21 (1) · Vaccines, Combined (1) · Typhoid-Paratyphoid Vaccines (1) · Meningococcal Vaccines (1) · DTaP-IPV-HB-PRP-T vaccine (1) · Oral Polio Vaccine (1)
Studies
Open first, then newest update. How each study uses Measles Vaccine is read from its arms, and is right about nine times in ten.
Testing it · 17
- Strengthening HPV Immunization Through EPI Leveraged DeliveryRecruitingPhase 2International Vaccine InstituteNCT07377656Written as Measles and rubella Vaccine
- Measles Vaccination at Health System ContactsEnrolling by invitationPhase 4Bandim Health ProjectNCT04220671Written as measles vaccine
- Measles and BCG Vaccines for Mother and ChildRecruitingPhase 4Bandim Health ProjectNCT04899765Written as Measles vaccine
- Infant Malaria Vaccine Schedule OptimizationActive, not recruitingPhase 2PATHNCT06879327Written as Measles and Rubella Vaccine
- A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and InfantsCompletedPhase 2GlaxoSmithKlineNCT06213506Written as Measles and Rubella vaccine
- Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South AfricaCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT05794230Written as Measles vaccine
- Vaccine Campaign Effects on General Hospital Admissions and Mortality Among ChildrenCompletedPhase 4Bandim Health ProjectNCT03460002Written as Measles vaccine
- A Second Dose of Measles Vaccine (MV) in the Second Year of LifeCompletedNot applicableBandim Health ProjectNCT02943681Written as Measles vaccine
- Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and RubellaCompletedPhase 2/3The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)NCT03148990Written as Measles and Rubella vaccine
- Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A VaccineStatus unknownPhase 4University of Witwatersrand, South AfricaNCT03330171Written as Measles vaccine
- Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles VaccineCompletedPhase 3PATHNCT00249769Written as Measles Vaccine (MV)
- Randomized Controlled Trial of Measles Vaccination ScheduleStatus unknownNot applicablePost Graduate Institute of Medical Education and Research, ChandigarhNCT03170765Written as Measles vaccine
- Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and RubellaCompletedPhase 1The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)NCT02196285Written as Double viral (MR) vaccine
- Additional Measles Vaccine at 4 Months of AgeStatus unknownPhase 4Bandim Health ProjectNCT01486355Written as Measles vaccine
- Early Two-dose Measles Vaccination TrialCompletedPhase 4Bandim Health ProjectNCT00168558Written as Measles vaccine
- Long-term Follow-up of Measles AntibodiesCompletedPhase 4Bandim Health ProjectNCT00168571Written as Measles vaccine
- Immunology of Non-specific Effects of VaccineCompletedPhase 4Bandim Health ProjectNCT00168545Written as Measles vaccine
Given in every arm · 3 — Measles Vaccine is usual care beside what is tested
- Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)CompletedPhase 3GlaxoSmithKlineNCT01345240Written as Measles vaccine
- Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in MaliCompletedPhase 4PATHNCT02286895Written as measles vaccine (MV)
- Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African InfantsCompletedPhase 2GlaxoSmithKlineNCT01231503Written as Rouvax